| REVEAL III: Risk Evaluation and Education for Alzheimer's Disease (NCT00462917) | Brigham and Women's Hospital | 2007-03-01 |
| Disease-modifying Properties of Lithium in the Neurobiology of Alzheimer's Disease (NCT01055392) | University of Sao Paulo | 2007-03-01 |
| A Study of V950 in People With Alzheimer Disease (V950-001 AM7) (NCT00464334) | Merck Sharp & Dohme LLC | 2007-03-01 |
| Deep Brain Stimulation (DBS) for Alzheimer's Disease (NCT00658125) | University Health Network, Toronto | 2007-03-01 |
| Rivastigmine in Mild Alzheimer's Disease, FMRI Study (NCT00627848) | Kuopio University Hospital | 2007-03-01 |
| Evaluation of 123-I Iodobenzovesamicol (IBVM) and SPECT Imaging of Healthy Subjects and Patients With Alzheimer Disease (NCT00480701) | Institute for Neurodegenerative Disorders | 2007-02-01 |
| Single Ascending Dose Study of SRA-444 in Healthy Subjects (NCT00452504) | Wyeth is now a wholly owned subsidiary of Pfizer | 2007-02-01 |
| GLP-1 Receptor Agonists and Alzheimer's Disease: A Multi-National Target Trial Emulation (NCT07677865) | West China Hospital | 2007-01-01 |
| Development of NIC5-15 in the Treatment of Alzheimer's Disease (NCT00470418) | VA Office of Research and Development | 2007-01-01 |
| DC Longitudinal Study on Aging and Specimen Bank (NCT03702907) | Georgetown University | 2007-01-01 |
| Partners in Dementia Care: A Telephone Care Consultation Intervention Provided to Veterans in Partnership With Local Alzheimer's Association Chapters (NCT00291161) | VA Office of Research and Development | 2006-12-01 |
| GTS21-201 for Alzheimer Disease:GTS-21 Administered Daily for 28 Days to Participants With Probable Alzheimer's Disease (NCT00414622) | CoMentis | 2006-11-01 |
| Prevalence of Alzheimer's Disease Pathology in the Community (NCT06719453) | Helse Stavanger HF | 2006-10-03 |
| Exercise Treatment of Mild-Stage Probable Alzheimer's Disease (NCT00403507) | Intermountain Health Care, Inc. | 2006-10-01 |
| Study Evaluating Single Ascending Doses of AAB-001 Vaccine SAD Japanese Patients With Alzheimers Disease (NCT00397891) | Wyeth is now a wholly owned subsidiary of Pfizer | 2006-10-01 |
| Activity of AVE1625 in Mild to Moderate Alzheimer's Patients. (NCT00380302) | Sanofi | 2006-09-01 |
| Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SAM-315 in Healthy Japanese Males (NCT00480467) | Wyeth is now a wholly owned subsidiary of Pfizer | 2006-09-01 |
| Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of SAM-531 in Healthy Young and Elderly Subjects (NCT00480818) | Wyeth is now a wholly owned subsidiary of Pfizer | 2006-09-01 |
| Raloxifene for Women With Alzheimer's Disease (NCT00368459) | Stanford University | 2006-08-01 |
| Study Evaluating the Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of SAM-315 in Healthy Adults (NCT00479440) | Wyeth is now a wholly owned subsidiary of Pfizer | 2006-08-01 |
| A Study of Healthy Subjects to Assess the Effect of LY450139 on Amyloid Beta Peptide Production Rate and or Dose Response. (NCT00765115) | Eli Lilly and Company | 2006-07-01 |
| Study Evaluating PAZ-417 in Healthy Young/Elderly (NCT00366288) | Wyeth is now a wholly owned subsidiary of Pfizer | 2006-07-01 |
| Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SAM-531 in Healthy Japanese Males (NCT00479297) | Wyeth is now a wholly owned subsidiary of Pfizer | 2006-05-01 |
| Global Efficacy Study of MPC-7869 to Treat Patients With Alzheimer's (NCT00322036) | Myrexis Inc. | 2006-05-01 |
| Study Evaluating the Safety of Lecozotan SR in Healthy Young and Elderly Subjects (NCT00366483) | Wyeth is now a wholly owned subsidiary of Pfizer | 2006-05-01 |
| Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SAM-531 in Healthy Subjects (NCT00479700) | Wyeth is now a wholly owned subsidiary of Pfizer | 2006-05-01 |
| Enhancing Consent for Alzheimer's Research (NCT00453544) | University of California, San Diego | 2006-04-01 |
| Study Evaluating the Safety, Tolerability, and Efficacy of Lecozotan SR in Outpatients With Alzheimer's Disease (NCT00277810) | Pfizer | 2006-03-01 |
| Long-term Use of Galantamine Versus Nootropics (Memory Enhancing Drugs) in Patients With Alzheimer's Dementia Under Conditions of Daily Routine (NCT01009476) | Janssen-Cilag G.m.b.H | 2006-03-01 |
| Assess 123-I IMPY and SPECT Imaging as a Tool to Detect β-Amyloid in the Brain (NCT00287248) | Institute for Neurodegenerative Disorders | 2006-02-01 |
| Enhancing Care Coordination: Hospital to Home for Cognitively Impaired Older Adults and Their Caregivers (NCT00294307) | University of Pennsylvania | 2006-02-01 |
| Detecting an Early Response to Donepezil With Measures of Visual Attention (NCT03073876) | NYU Langone Health | 2005-12-01 |
| The Depression in Alzheimer's Disease Study (DIADS) (NCT00009191) | Johns Hopkins University | 2005-11-01 |
| Study Evaluating Lecozotan SR in Mild to Moderate Alzheimer's Disease (AD) (NCT00151398) | Wyeth is now a wholly owned subsidiary of Pfizer | 2005-10-06 |
| A Safety and Tolerability Evaluation of Two 10-Week Dose Regimens of Orally-Administered PF-04494700 in Alzheimer's Patients (NCT00141661) | Pfizer | 2005-10-01 |
| Using Behavioral Programs to Treat Sleep Problems in Individuals With Alzheimer's Disease (NCT00183378) | University of Washington | 2005-09-01 |
| Telehealth Education Program for Caregivers of Veterans With Dementia (NCT00105638) | US Department of Veterans Affairs | 2005-09-01 |
| Effects of Sage on Memory and Mental Performance in Alzheimer's Disease Patients (NCT00110552) | Oregon Health and Science University | 2005-07-01 |
| Effect of EGb 761® on Patients With Mild to Moderate Alzheimer's Disease (NCT00500500) | Ipsen | 2005-07-01 |
| Systematic Care for Informal Caregivers of Dementia Patients: An Efficient Approach? (NCT00147693) | Radboud University Medical Center | 2005-06-01 |
| An Observational Study of the Safety and Effectiveness of Galantamine in the Treatment of Patients With Alzheimer's Disease Over an 18-month Period (NCT00299676) | Janssen-Cilag Pty Ltd | 2005-05-01 |
| The Effect of Memantine on Brain Structure and Chemistry in Alzheimer's Disease Patients (NCT00255086) | Stanford University | 2005-05-01 |
| Study of the Effect of SR57667B in Patients With Alzheimer's Disease (NCT00285025) | Sanofi | 2005-03-01 |
| Efficacy Study of MPC-7869 to Treat Patients With Alzheimer's (NCT00105547) | Myrexis Inc. | 2005-02-01 |
| Evaluating Simvastatin's Potential Role in Therapy (NCT00486044) | University of Wisconsin, Madison | 2005-02-01 |
| Testing the Effectiveness of Telephone Support for Dementia Caregivers (NCT00119561) | US Department of Veterans Affairs | 2005-02-01 |
| The Chinese Familial Alzheimer's Network (NCT03657732) | Capital Medical University | 2005-01-10 |
| Association of Anticholinergic Burden With Onset of Delirium in Older Adults With Alzheimer Dementia: (NCT05055895) | Gulhane Training and Research Hospital | 2005-01-01 |
| Life From Vision in Alzheimer Disease (NCT00838942) | Assistance Publique - Hôpitaux de Paris | 2004-12-01 |
| Couples Coping With Alzheimer's Disease (NCT00438724) | Alzheimer's Association | 2004-11-01 |
| Comparative Study to Test Safety and Efficacy of Neurotrophic and Cholinergic Treatment of Alzheimer's Disease (NCT00911807) | Ever Neuro Pharma GmbH | 2004-10-01 |
| Antipsychotic Discontinuation in Alzheimer's Disease (NCT00417482) | New York State Psychiatric Institute | 2004-08-01 |
| Effect of Lithium and Divalproex in Alzheimer's Disease (NCT00088387) | National Institute of Neurological Disorders and Stroke (NINDS) | 2004-07-01 |
| A Study of the Safety and Effectiveness of Galantamine Hydrobromide in Patients With Alzheimer's Disease (NCT00297362) | Janssen Cilag Pharmaceutica S.A.C.I., Greece | 2004-06-01 |
| Evaluation of 3APS in Patients With Mild to Moderate Alzheimer's Disease (NCT00088673) | Bellus Health Inc. - a GSK company | 2004-06-01 |
| PET Study of Acetylcholine Esterase Activity in Alzheimer's Disease (NCT06180252) | IRCCS San Raffaele | 2004-05-12 |
| PET Changes in Alzheimer's Disease (AD) (NCT00094913) | National Institute on Aging (NIA) | 2004-05-01 |
| Huperzine A in Alzheimer's Disease (NCT00083590) | National Institute on Aging (NIA) | 2004-04-01 |
| Long-Term Safety Extension With SR57667B in Patients With Alzheimer's Disease (NCT00285077) | Sanofi | 2004-03-01 |
| A Randomized, Double-blind, Flexible Dose, Multicenter Study to Evaluate the Effectiveness and Safety of Galantamine IR in Mild to Moderate Alzheimer's Disease (NCT00645190) | Xian-Janssen Pharmaceutical Ltd. | 2004-03-01 |
| The Efficacy of Galantamine on the Attention and the Frontal Function of the Patients With Dementia of Alzheimer Type (NCT00216515) | Janssen Korea, Ltd., Korea | 2004-03-01 |
| Improving Mood and Behavior in Assisted Living Residents Through Skills Training for Their Caregivers (NCT00255866) | University of Washington | 2004-01-01 |
| Treatment of Severe Alzheimer's Disease: Evaluation of Efficacy and Safety of Galantamine Hydrobromide in a Controlled Study (NCT00216593) | Janssen Pharmaceutica N.V., Belgium | 2003-12-01 |
| Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation (ALADDIN) VP 104 Study (NCT00076440) | Voyager Pharmaceutical Corporation | 2003-12-01 |
| 18-Month Study of the Efficacy of Xaliproden (SR57746A) in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type (NCT00103649) | Sanofi | 2003-11-01 |
| Study of Xaliproden (SR57746A) in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type (NCT00104013) | Sanofi | 2003-11-01 |
| Adding Atomoxetine To Standard Medication Treatment In Patients With Alzheimer's Disease (NCT00191009) | Eli Lilly and Company | 2003-10-01 |
| Apathy Associated With Alzheimer's Disease (NCT00254033) | Sunnybrook Health Sciences Centre | 2003-10-01 |
| Valproate in Dementia (VALID) (NCT00071721) | Alzheimer's Disease Cooperative Study (ADCS) | 2003-10-01 |
| The Serotonergic Transmitter System in Dementia and Affective Disorders (NCT00192998) | Rigshospitalet, Denmark | 2003-10-01 |
| A Comparison of Two Standard Therapies in the Management of Dementia With Agitation (NCT00208819) | Emory University | 2003-09-01 |
| Predictors of Cognitive Decline in Normal Aging (NCT00094939) | National Institute on Aging (NIA) | 2003-09-01 |
| An Innovative Psychosocial Intervention for Adult-Child Caregivers of Parents With Alzheimer's Disease (NCT00409279) | The Jacob and Valeria Langeloth Foundation | 2003-09-01 |
| Treatment of Language and Memory in Patients With Alzheimer's Disease (NCT00593372) | University of Arkansas | 2003-08-01 |
| The Dementia Study in Northern Norway (NCT00443014) | University Hospital of North Norway | 2003-06-01 |
| Risk Evaluation and Education for Alzheimer's Disease (REVEAL) II (NCT00089882) | National Institute on Aging (NIA) | 2003-05-01 |
| ALADDIN Study: Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation (NCT00063310) | Voyager Pharmaceutical Corporation | 2003-03-01 |
| An Evaluation of Three Doses of NS 2330 in Patients With Mild to Moderate Dementia of the Alzheimer's Type (NCT00153010) | Boehringer Ingelheim | 2003-02-01 |
| Alzheimer's Disease Treatment and Illness Perceptions Survey (TIPS) II (NCT00059410) | Alzheimer's Association | 2003-01-01 |
| Cholesterol Lowering Agent to Slow Progression (CLASP) of Alzheimer's Disease Study (NCT00053599) | National Institute on Aging (NIA) | 2002-12-01 |
| A Multi-Center, Randomized, Double-Blind, Parallel Group Study With 3 Groups Receiving Placebo, 5 mg of E2020 and 10 mg of E2020 (NCT00165659) | Eisai Limited | 2002-11-01 |
| A Study of the Efficacy and Safety of Aricept in Patients With Severe Alzheimer's Disease Who Are Living in Skilled Nursing Homes (NCT00630851) | Pfizer | 2002-10-01 |
| The Effect of Short-Term Statins and NSAIDs on Levels of Beta-Amyloid, a Protein Associated With Alzheimer's Disease (NCT00046358) | National Institute of Mental Health (NIMH) | 2002-09-01 |
| Bathing Persons With Alzheimer's Disease aT Home (The BATH Study) (NCT00062569) | National Institute of Nursing Research (NINR) | 2002-09-01 |
| A Survey Study of the Treatment and Outcome Management in Patients Diagnosed With Alzheimer's Disease (NCT00291421) | Janssen Pharmaceutica N.V., Belgium | 2002-07-01 |
| Alzheimer's Disease Genetics Study (NCT00064870) | Indiana University | 2002-06-01 |
| Coordinating Center for Caregiver Intervention Trial (NCT00177489) | University of Pittsburgh | 2002-06-01 |
| Brain Imaging in Alzheimer's Disease (NCT00039702) | National Institute of Mental Health (NIMH) | 2002-06-01 |
| Treatment for Early Memory Loss (NCT00042172) | University of Iowa | 2002-06-01 |
| Prevention of Alzheimer's Disease by Vitamin E and Selenium (PREADVISE) (NCT00040378) | Frederick Schmitt | 2002-05-01 |
| Vitamin E in Aging Persons With Down Syndrome (NCT00056329) | New York State Institute for Basic Research | 2002-04-01 |
| Pioglitazone in Alzheimer Disease (NCT00982202) | National Institute on Aging (NIA) | 2002-01-01 |
| Evaluation of Age- and Alzheimer's Disease-Related Memory Disorder (NCT00029120) | National Institute of Mental Health (NIMH) | 2001-12-18 |
| Alzheimer's Disease: Therapeutic Potential of Estrogen (NCT00066157) | University of Wisconsin, Madison | 2001-09-01 |
| Cognitive and Neurophysiological Effects of Raloxifene in Alzheimer's Disease (NCT00065767) | University of Wisconsin, Madison | 2001-09-01 |
| A Study of the Safety and Effectiveness of Galantamine in Patients With Alzheimer's Disease (NCT00216502) | Janssen-Cilag S.p.A. | 2001-08-01 |
| PET Study of the Nicotinic Receptors in Human (NCT00543322) | Commissariat A L'energie Atomique | 2001-07-01 |
| A Study to Evaluate the Efficacy and Safety of Galantamine in Patients With Mild Cognitive Impairment (NCT00236431) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2001-05-01 |
| A Study to Evaluate the Efficacy and Safety of Galantamine in Patients With Mild Cognitive Impairment (NCT00236574) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2001-05-01 |
| An Efficacy and Safety Study of Galantamine for the Treatment of Patients With Alzheimer's Disease. (NCT00301574) | Janssen Pharmaceutical K.K. | 2001-04-01 |